Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Oral semaglutide demonstrated cardiovascular safety in people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk in PIONEER 6 trial 2019-06-12 02:45
Amcor Completes Acquisition of Bemis, Creating the Global Leader in Consumer Packaging 2019-06-12 02:26
TauRx Recognized as a Technology Innovation Leader in the Neurodegenerative Disease Management Industry 2019-06-11 08:00
Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device 2019-06-10 21:00
Oral semaglutide showed superior reductions in blood sugar vs Jardiance® and non-inferior blood sugar reductions vs Victoza® in adults with type 2 diabetes at 26 weeks 2019-06-08 23:45
ESPGHAN Researchers Warn: Junk Food Could Be Responsible for the Food Allergy Epidemic 2019-06-08 07:01
Innovent provides Update on the Results of Sintilimab for the Treatment of Extranodal NK/T Cell Lymphoma by Oral Presentation at ASCO 2019-06-05 08:00
RemeGen, Ltd. Announces Positive Results from RC48 Clinical Trial in HER2-Positive Metastatic or Unresectable Urothelial Cancer 2019-06-04 21:00
Innovent Provides Update on ctDNA in Predicting Response and Resistance by Anti-PD-1 Therapy in Chinese Relapsed/Refractory Classical Hodgkin Lymphoma 2019-06-04 08:00
Innovent Provides Updates on Extended Follow-up on Sintilimab for Relapsed/Refractory Classical Hodgkin's Lymphoma 2019-06-04 08:00
Innovent Provides Update on Sintilimab in Combination with CAPOX for First-Line Treatment of Patients with Gastric or Gastroesophageal Junction Carcinoma (GC/GEJC) 2019-06-04 08:00
Merck Presents Updated Results for Investigational Therapy Tepotinib Demonstrating Durable Clinical Response in Patients with Advanced NSCLC with METex14 Skipping Mutations 2019-06-04 02:16
Frost & Sullivan Publishes Q1 Update on Kadimastem 2019-06-03 21:24
Updated Results on Neoadjuvant PD-1 Blockade with Sintilimab in Resectable Squamous Non-Small Cell Lung Cancer (sqNSCLC) at ASCO, Led by Professor Jie He, Dean of the Cancer Hospital of the Chinese Academy of Medical Sciences 2019-06-03 08:00
Innovent Provides Key Results Update of IBI305 (Biosimilar Product Candidate of Bevacizumab) Compared with Bevacizumab 2019-06-03 08:00
Sihuan Pharm Post-launching Large-scale Clinical Trials of Cinepazide Maleate Injection were Completed With Efficacy Verified 2019-06-01 11:18
Innovent Provides Update on Phase Ib Study of Sintilimab in Combination with Chemotherapy for First-line Advanced or Metastatic Non-small Cell Lung Cancer 2019-05-31 08:00
Luye Pharma's Rykindo® NDA Filing Accepted by the U.S. FDA 2019-05-30 13:09
PHS Health Solutions Unveils Company Rebrand to Amplity Health 2019-05-29 22:00
IMI launches IMI Corporate Wellness amidst growing concerns for professionals' wellbeing. 2019-05-28 09:15
1 178 179 180 181 182 229